Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update

<i>ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the</i> <i>ASCO Guideline Methodology Manual</i>. <i>The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).</i>

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-04-29
DOI
https://doi.org/10.1200/jco-25-00250
Citations
7
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
11.38
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update

Andreas Felix Hottinger, Na Tosha Gatson, Martin J. van den Bent, Roy E. Strowd et al.
7 citations
Journal of Clinical Oncology
Glioma Diagnosis and Treatment
11.38
article

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update

Andreas Felix Hottinger, Na Tosha Gatson, Martin J. van den Bent, Roy E. Strowd, David Schiff, Anne Shannon, Jordan Morton, Phioanh Leia Nghiemphu, Hans J. Messersmith, Helen Alice Shih, Mateo Ziu, Jaishri O. Blakeley, Douglas Ney, Andrew B. Lassman, Nimish Mohile, James Perry
article en
7 citations

Abstract

<i>ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the</i> <i>ASCO Guideline Methodology Manual</i>. <i>The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).</i>

Journal of Clinical OncologyVol. 43(18)
American Society of Clinical Oncology (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), University of Rochester Medical Center (US), University of Virginia Medical Center (US), Herbert Irving Comprehensive Cancer Center, Columbia University (US)
Openalex Percentile: Top 1%
Glioma Diagnosis and Treatment
11.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.